• Member News

LUNAC Therapeutics appoints Carl Sterritt as Chief Executive Officer

LUNAC Therapeutics Ltd (LUNAC), a UK-based drug discovery company focused on the development of advanced life-saving anticoagulants with minimal risk of bleeding, announces that it has appointed Carl Sterritt as Chief Executive Officer.

Covid testing pioneer named as a BioBusiness Mover and Shaker

Dr Sally Price, Head of Cell and Translational Science at Medicines Discovery Catapult (MDC) has been named in BioBeat’20 Movers & Shakers in BioBusiness 2020.

Selvita to acquire Fidelta from Galapagos

Strengthening Selvita’s position as one of the largest preclinical contract research organizations in Europe - Acquisition substantially expands Selvita’s integrated drug discovery services offering - Transaction will almost double Selvita’s revenues - Enterprise value of € 31.2M to be paid in cash - Fidelta to continue performing drug discovery services for Galapagos for the next five years

Pharmaceutical Investment Recovery & Redeployment Solutions

Sell or redeploy equipment from multiple sites within your company with EquipNet’s Surplus Asset Management Program.

Abzena upgrades GMP chemistry and conjugation suites to allow Phase III and commercial manufacturing

Abzena, a global partner research organization for integrated bench to market solutions for biologics and bioconjugates, has announced upgrades of its chemistry GMP suites.

University of Exeter and Medicines Discovery Catapult combine to industrialise academic medicines research

Today, the University of Exeter and Medicines Discovery Catapult (MDC) announce their strategic partnership to accelerate medicines Research & Development (R&D), creating value for the sector and enhancing translational skills.

PhoreMost and Oxford Biomedica enter gene therapy discovery collaboration

• Collaboration to develop next-generation CAR-T cell therapies with improved efficacy and durability • PhoreMost’s SITESEEKER® platform will identify active peptides to be deployed within Oxford Biomedica’s LentiVector ® delivery system

Neuroscience-focused CRO Transpharmation opening new facility at Discovery Park

Sandwich, Kent, November 4 2020 - Discovery Park, the Life Sciences Opportunity Zone for ambitious and growing life sciences companies, is pleased to welcome contract research organisation Transpharmation Ltd as a new tenant.

Coulter Partners announces new appointments in the US, London and Denmark

Global executive search specialist, Coulter Partners is delighted to announce a number of key hires in 2020. Marianne McNamara, SHRM-SCP has joined as Operations Director for the US, while Evan Fishel is appointed Director on the West Coast and Mike Miano, Senior Associate in New Jersey. In London the team is strengthened with Ben Hobbins as Senior Consultant and Hafsah Bhatti as Associate, while research capacity is also expanded across the team.

Mogrify appoints Profs. Christine Mummery, Graziella Pellegrini and Giulio Cossu to Scientific Advisory Board

Leaders in stem cell research and cell therapy to help drive development of scalable off-the-shelf therapies for diseases with a high unmet clinical need